INFLARX: SUBSEQUENT POST-HOC ANALYSES SUGGEST POSITIVE TREND IN FAVOR OF VILOBELIMAB, WITH SIGNALS INDICATING POTENTIALLY CONSISTENT TREATMENT EFFECT

Reuters · 12/30/2025 12:30

Please log in to view news